SELENOS and COVID-19: Given the aforementioned high correlation between dietary selenium (from nutritional to apparently supranutritional levels) and survival percentage following viral infection in mice [152], the dramatic reduction of hantavirus-associated fatality rate in humans after the treatment with a pharmacological dose of selenite [46], and the fact that the cure rate of COVID-19 patients continued to rise beyond the selenium intake required to optimise selenoprotein requirements [7], it is anticipated that redox-active metabolites of supranutritional selenium could also inhibit the Mpro of SARS-CoV-2.